FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379283634> ?p ?o ?g. }

• W4379283634 endingPage "e13633" @default.
• W4379283634 startingPage "e13633" @default.
• W4379283634 abstract "e13633 Background: YouTube is an open-access source of information with more than 2.5 billion users. It plays an important role in disseminating information especially related to health, including cancer. Chimeric antigen receptor-T (CAR-T) cell therapy has significantly improved outcomes for hematologic malignancies over recent years. We aim to assess the quality and engagement parameters of the 100 most viewed videos on YouTube on CAR-T cell therapy. Methods: A systematic search was conducted on YouTube using the search terms (“CAR-T Cell therapy” AND “Cancer”). One hundred most viewed videos in English were selected. We utilized the already validated tools PEMAT 1 and DISCERN 2 to assess the quality of these videos on CAR-T. Additionally, we looked at the number of views, comments, and likes. Descriptive statistics and Pearson correlation tests were performed using R studio v2022.12.0-353. Results: The videos in our study had up to 3.4 million views (median number of views:19,901), and the overall quality of information was fair (50%) by the DISCERN score. These videos were categorized into different sources academic (60%), media (22%), and industry (18%). The mean DISCERN score (44.27± 10.8), mean PEMAT actionability (47% ± 38%), mean PEMAT understandability (75.6% ± 15.5%). While benefits were mentioned by 67%, only 29% discussed the risks of CAR-T Cell therapy; 37% of videos promoted shared decision-making, and only 10% summarized the information at the end as per the DISCERN criteria. There was no significant correlation between DISCERN and PEMAT scores with video engagement parameters, including likes, views, and comments. Furthermore, only 30% of videos discussed other treatment options except for CAR-T. While 88% of videos used everyday language, medical terminologies were defined by 73% of videos; 32 % of videos were broken into short sections with informative headers as per the PEMAT criteria. Conclusions: To the best of our knowledge, this is the first study evaluating the quality of information on CAR-T cell therapy on YouTube. In comparison to previous studies using YouTube 3,4 , this study shows the quality of the information provided in these videos is valid and reliable. They also prove to be actionable and understandable; these videos focus on the benefits of CAR-T cell therapy and are less likely to discuss risks or shared decision-making. We believe YouTube videos on CAR-T Cell therapy may serve as a supplementary source of providing information to patients wishing to learn more on this topic. 1) Shoemaker SJ et al. The Patient Education Materials Assessment Tool (PEMAT) and User’s Guide. 2) Charnock D et al. DISCERN: an instrument for judging the quality of written consumer health information on treatment choices. 3) Steinberg et al. YouTube as Source of Prostate Cancer Information, Urology. 4) Di Bello et al. Immunotherapy for Urological Tumors on YouTube: An Information-Quality Analysis, Vaccines." @default.
• W4379283634 created "2023-06-05" @default.
• W4379283634 creator A5002954178 @default.
• W4379283634 creator A5029003401 @default.
• W4379283634 creator A5042456649 @default.
• W4379283634 creator A5054741163 @default.
• W4379283634 creator A5059162284 @default.
• W4379283634 creator A5067131406 @default.
• W4379283634 creator A5074545368 @default.
• W4379283634 creator A5088955514 @default.
• W4379283634 date "2023-06-01" @default.
• W4379283634 modified "2023-10-16" @default.
• W4379283634 title "Quality assessment of information on chimeric antigen receptor T-cell therapy on YouTube: An analysis." @default.
• W4379283634 doi "https://doi.org/10.1200/jco.2023.41.16_suppl.e13633" @default.
• W4379283634 hasPublicationYear "2023" @default.
• W4379283634 type Work @default.
• W4379283634 citedByCount "0" @default.
• W4379283634 crossrefType "journal-article" @default.
• W4379283634 hasAuthorship W4379283634A5002954178 @default.
• W4379283634 hasAuthorship W4379283634A5029003401 @default.
• W4379283634 hasAuthorship W4379283634A5042456649 @default.
• W4379283634 hasAuthorship W4379283634A5054741163 @default.
• W4379283634 hasAuthorship W4379283634A5059162284 @default.
• W4379283634 hasAuthorship W4379283634A5067131406 @default.
• W4379283634 hasAuthorship W4379283634A5074545368 @default.
• W4379283634 hasAuthorship W4379283634A5088955514 @default.
• W4379283634 hasConcept C105795698 @default.
• W4379283634 hasConcept C111472728 @default.
• W4379283634 hasConcept C121608353 @default.
• W4379283634 hasConcept C126322002 @default.
• W4379283634 hasConcept C138885662 @default.
• W4379283634 hasConcept C162324750 @default.
• W4379283634 hasConcept C176217482 @default.
• W4379283634 hasConcept C21547014 @default.
• W4379283634 hasConcept C2777701055 @default.
• W4379283634 hasConcept C2779346075 @default.
• W4379283634 hasConcept C2779530757 @default.
• W4379283634 hasConcept C33923547 @default.
• W4379283634 hasConcept C3875195 @default.
• W4379283634 hasConcept C39896193 @default.
• W4379283634 hasConcept C71924100 @default.
• W4379283634 hasConceptScore W4379283634C105795698 @default.
• W4379283634 hasConceptScore W4379283634C111472728 @default.
• W4379283634 hasConceptScore W4379283634C121608353 @default.
• W4379283634 hasConceptScore W4379283634C126322002 @default.
• W4379283634 hasConceptScore W4379283634C138885662 @default.
• W4379283634 hasConceptScore W4379283634C162324750 @default.
• W4379283634 hasConceptScore W4379283634C176217482 @default.
• W4379283634 hasConceptScore W4379283634C21547014 @default.
• W4379283634 hasConceptScore W4379283634C2777701055 @default.
• W4379283634 hasConceptScore W4379283634C2779346075 @default.
• W4379283634 hasConceptScore W4379283634C2779530757 @default.
• W4379283634 hasConceptScore W4379283634C33923547 @default.
• W4379283634 hasConceptScore W4379283634C3875195 @default.
• W4379283634 hasConceptScore W4379283634C39896193 @default.
• W4379283634 hasConceptScore W4379283634C71924100 @default.
• W4379283634 hasIssue "16_suppl" @default.
• W4379283634 hasLocation W43792836341 @default.
• W4379283634 hasOpenAccess W4379283634 @default.
• W4379283634 hasPrimaryLocation W43792836341 @default.
• W4379283634 hasRelatedWork W1980486870 @default.
• W4379283634 hasRelatedWork W2001395945 @default.
• W4379283634 hasRelatedWork W2130472920 @default.
• W4379283634 hasRelatedWork W2139494366 @default.
• W4379283634 hasRelatedWork W2365364931 @default.
• W4379283634 hasRelatedWork W2393598789 @default.
• W4379283634 hasRelatedWork W2418638721 @default.
• W4379283634 hasRelatedWork W2883190832 @default.
• W4379283634 hasRelatedWork W2892153935 @default.
• W4379283634 hasRelatedWork W3005601594 @default.
• W4379283634 hasVolume "41" @default.
• W4379283634 isParatext "false" @default.
• W4379283634 isRetracted "false" @default.
• W4379283634 workType "article" @default.